ThrombolysisDissolutionof bloodclotsVitaminKantidoteforwarfarinRivaroxabandirect factor Xainhibitor prototypethat inhibits plateletactivation andformation of fibrinclotting by inhibitionof factor XaIdarucizumabAntidotefordabigatranPTTandINRLaboratorytests used tomanagetherapeuticrange ofwarfarin3QSEN Alert: Thenurse should holdthe dose of warfarinif the INR is abovethis number andnotify the healthcare providerHemorrhagemajor sideeffect ofHeparintherapyDisseminatedintravascularcoagulation(DIC)Heparin is used totreat this life-threatening conditioncharacterized bywidespread clotting,which depletes theblood of coagulationfactors.ProtamineSulfateAntidoteforheparinalteplaseprototypethrombolyticdrugThrombolyticDrugsagentsthatdissolveblood clotsPlasminogenAn inactive proteinpresent in many bodytissues and fluids thatis bound to fibrin andbecomes acomponent of a bloodclotClopidogrelprototype Adenosinediphosphate receptorantagonist thatirreversibly blocks theADP receptor onplatelet cell surface.HomeostasisProcess thatmaintains theintegrity ofthe vascularcompartment.Heparininhibits theconversion ofprothrombin tothrombin andprevents thrombusformationHeparin inducedthrombocytopenia(HIT)A potentially life-threateningcomplication of heparinadministration leadingto a decrease inplatelet count anddetectable HITantibodiestranexamicacidReversal ofthrombolytic agentused for short periodsin patients withhemophilia to preventor decrease breedingform tooth extraction ormenorrhagia.warfarinPrototypevitamin KantagonistdabigatranThe onlyoral directthrombininhibitorPCCReversal ofwarfarin overdosewith acute majorbleeding or inneed of emergentsurgeryaPTTlaboratory testused to see ifheparin iswithintherapeuticrangeAminocaproicacidReversal ofthrombolytic agentused in cardiacsurgery, blooddisorders, hepaticcirrhosis,prostatectomy, andneoplastic disordersDVTand PEHeparin isgivenprophylacticallyto patients toprevent theseActionofwarfarinActs in theliver topreventsynthesis ofvitamin KThrombolysisDissolutionof bloodclotsVitaminKantidoteforwarfarinRivaroxabandirect factor Xainhibitor prototypethat inhibits plateletactivation andformation of fibrinclotting by inhibitionof factor XaIdarucizumabAntidotefordabigatranPTTandINRLaboratorytests used tomanagetherapeuticrange ofwarfarin3QSEN Alert: Thenurse should holdthe dose of warfarinif the INR is abovethis number andnotify the healthcare providerHemorrhagemajor sideeffect ofHeparintherapyDisseminatedintravascularcoagulation(DIC)Heparin is used totreat this life-threatening conditioncharacterized bywidespread clotting,which depletes theblood of coagulationfactors.ProtamineSulfateAntidoteforheparinalteplaseprototypethrombolyticdrugThrombolyticDrugsagentsthatdissolveblood clotsPlasminogenAn inactive proteinpresent in many bodytissues and fluids thatis bound to fibrin andbecomes acomponent of a bloodclotClopidogrelprototype Adenosinediphosphate receptorantagonist thatirreversibly blocks theADP receptor onplatelet cell surface.HomeostasisProcess thatmaintains theintegrity ofthe vascularcompartment.Heparininhibits theconversion ofprothrombin tothrombin andprevents thrombusformationHeparin inducedthrombocytopenia(HIT)A potentially life-threateningcomplication of heparinadministration leadingto a decrease inplatelet count anddetectable HITantibodiestranexamicacidReversal ofthrombolytic agentused for short periodsin patients withhemophilia to preventor decrease breedingform tooth extraction ormenorrhagia.warfarinPrototypevitamin KantagonistdabigatranThe onlyoral directthrombininhibitorPCCReversal ofwarfarin overdosewith acute majorbleeding or inneed of emergentsurgeryaPTTlaboratory testused to see ifheparin iswithintherapeuticrangeAminocaproicacidReversal ofthrombolytic agentused in cardiacsurgery, blooddisorders, hepaticcirrhosis,prostatectomy, andneoplastic disordersDVTand PEHeparin isgivenprophylacticallyto patients toprevent theseActionofwarfarinActs in theliver topreventsynthesis ofvitamin K

Chapter 9 Drug Therapy for Coagulation Disorders - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Dissolution of blood clots
    Thrombolysis
  2. antidote for warfarin
    Vitamin K
  3. direct factor Xa inhibitor prototype that inhibits platelet activation and formation of fibrin clotting by inhibition of factor Xa
    Rivaroxaban
  4. Antidote for dabigatran
    Idarucizumab
  5. Laboratory tests used to manage therapeutic range of warfarin
    PTT and INR
  6. QSEN Alert: The nurse should hold the dose of warfarin if the INR is above this number and notify the health care provider
    3
  7. major side effect of Heparin therapy
    Hemorrhage
  8. Heparin is used to treat this life-threatening condition characterized by widespread clotting, which depletes the blood of coagulation factors.
    Disseminated intravascular coagulation (DIC)
  9. Antidote for heparin
    Protamine Sulfate
  10. prototype thrombolytic drug
    alteplase
  11. agents that dissolve blood clots
    Thrombolytic Drugs
  12. An inactive protein present in many body tissues and fluids that is bound to fibrin and becomes a component of a blood clot
    Plasminogen
  13. prototype Adenosine diphosphate receptor antagonist that irreversibly blocks the ADP receptor on platelet cell surface.
    Clopidogrel
  14. Process that maintains the integrity of the vascular compartment.
    Homeostasis
  15. inhibits the conversion of prothrombin to thrombin and prevents thrombus formation
    Heparin
  16. A potentially life-threatening complication of heparin administration leading to a decrease in platelet count and detectable HIT antibodies
    Heparin induced thrombocytopenia (HIT)
  17. Reversal of thrombolytic agent used for short periods in patients with hemophilia to prevent or decrease breeding form tooth extraction or menorrhagia.
    tranexamic acid
  18. Prototype vitamin K antagonist
    warfarin
  19. The only oral direct thrombin inhibitor
    dabigatran
  20. Reversal of warfarin overdose with acute major bleeding or in need of emergent surgery
    PCC
  21. laboratory test used to see if heparin is within therapeutic range
    aPTT
  22. Reversal of thrombolytic agent used in cardiac surgery, blood disorders, hepatic cirrhosis, prostatectomy, and neoplastic disorders
    Aminocaproic acid
  23. Heparin is given prophylactically to patients to prevent these
    DVT and PE
  24. Acts in the liver to prevent synthesis of vitamin K
    Action of warfarin